Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycine cleavage system protein H (GCSH) is a heat-stable mitochondrial matrix protein with a covalently attached lipoic acid group that is essential for glycine catabolism. GCSH shuttles the methylamine group from glycine (initiated by the P protein/glycine decarboxylase) to the T protein (aminomethyltransferase) and undergoes oxidation (restoring its active site) by the L protein (dihydrolipoyl dehydrogenase). Its proper function is critical for one-carbon metabolism, providing essential methyl groups for biosynthesis (e.g., purines, methionine). Mutations in GCSH lead to rare but severe disorders (such as nonketotic hyperglycinemia) characterized by glycine accumulation, neurological dysfunction, and, in severe cases, embryonic lethality. GCSH may also participate in the lipoylation of other mitochondrial enzyme complexes. It is not a receptor, transporter, or ion channel but rather a mitochondrial enzyme cofactor and shuttle protein critical for amino acid metabolism. Clinical relevance is primarily in metabolic disease—in particular, congenital glycine encephalopathies. Loss of function can be highly lethal and is not currently amenable to direct drug targeting, but its pathway is under investigation for genetic and metabolic interventions.
Not applicable for direct drugs; pathogenesis involves loss-of-function mutation which disrupts glycine cleavage and methyl group transfer
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycine cleavage system protein H (GCSH).